Analystreport

NeuBase Therapeutics (NASDAQ: NBSE) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report